Compare RAMP & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RAMP | TMDX |
|---|---|---|
| Founded | 2018 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.6B |
| IPO Year | 1994 | 2019 |
| Metric | RAMP | TMDX |
|---|---|---|
| Price | $37.72 | $79.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 12 |
| Target Price | $38.70 | ★ $97.30 |
| AVG Volume (30 Days) | ★ 1.1M | 568.8K |
| Earning Date | 11-04-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22500.00 | 382.18 |
| EPS | 0.28 | ★ 0.61 |
| Revenue | ★ $812,940,000.00 | $605,494,000.00 |
| Revenue This Year | $8.97 | $22.50 |
| Revenue Next Year | $9.93 | $17.93 |
| P/E Ratio | ★ $134.38 | $137.66 |
| Revenue Growth | 9.03 | ★ 37.13 |
| 52 Week Low | $21.71 | $60.11 |
| 52 Week High | $38.23 | $156.00 |
| Indicator | RAMP | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 47.76 | 45.18 |
| Support Level | $37.33 | $80.29 |
| Resistance Level | $37.92 | $90.67 |
| Average True Range (ATR) | 0.17 | 3.55 |
| MACD | -0.01 | -0.53 |
| Stochastic Oscillator | 27.19 | 27.91 |
LiveRamp Holdings Inc is a technology company that empowers marketers and media owners to deliver and measure marketing performance everywhere it matters. Its data collaboration network seamlessly unites data across advertisers, ad tech platforms, publishers, data providers, and commerce media networks, unlocking insights that deliver transformational consumer experiences and drive measurable business outcomes. The group's platform is engineered for AI agent accessibility, facilitating autonomous data collaboration between the specialized AI agents utilized by customers and partners and the networked platform. It generates the geographic revenue from the United States, followed by Europe, Asia-Pacific ("APAC"), and Other.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.